National Cancer Institute – Cancer Adoptive Cellular Therapy Network (Can-ACT) for Adult Cancers Grant

The National Cancer Institute is offering the Cancer Adoptive Cellular Therapy Network (Can-ACT) grant to facilitate early adoptive cellular therapy clinical trials for adult and pediatric solid tumors. This initiative aims to accelerate the translation of new cell therapy strategies into clinical testing by promoting collaboration in preclinical testing and translational studies. Can-ACT will support multi-investigator teams with diverse expertise to advance innovative cell therapy products for cancer treatment. Applications for the grant are accepted until June 30, 2023.

Opportunity ID: 343239

Apply

General Information

Document Type::	Grants Notice
Funding Opportunity Number::	RFA-CA-22-028
Funding Opportunity Title::	Cancer Adoptive Cellular Therapy Network (Can-ACT) for Adult Cancers (UG3/UH3 Clinical Trial Required)
Opportunity Category::	Discretionary
Opportunity Category Explanation::
Funding Instrument Type::
Category of Funding Activity::	Education
Category Explanation::
Expected Number of Awards::
Assistance Listings Number(s)::	93.395 — Cancer Treatment Research
Cost Sharing or Matching Requirement::	No
Version::	Synopsis 1
Posted Date::	Aug 24, 2022
Last Updated Date::	Aug 24, 2022
Original Closing Date for Applications::	Jun 30, 2023
Current Closing Date for Applications::	Jun 30, 2023
Archive Date::	Aug 05, 2023
Estimated Total Program Funding::
Award Ceiling::	$
Award Floor::	$

Eligibility

Eligible Applicants::

County governments

Additional Information on Eligibility::

Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.

Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name::	National Institutes of Health
Description::	The National Cancer Institute (NCI) intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) soliciting UG3/UH3 applications for the Cancer Adoptive Cellular Therapy (Can-ACT) Network. The goal of this collaborative research network will be to stimulate the conduct of early adoptive cellular therapy clinical trials for adult and pediatric solid tumors. The emphasis is on accelerating the advancement of new cell therapy strategies into clinical testing through novel and collaborative approaches to preclinical testing and translational studies. Can-ACT will support multi-investigator teams with the relevant expertise, assembled to bring new cell therapy products to the clinic.
Link to Additional Information::
Grantor Contact Information::	If you have difficulty accessing the full announcement electronically, please contact:

Version History

Version	Modification Description	Updated Date
Synopsis 1		Aug 24, 2022

Package Status

Below are CLOSED Opportunity Package(s) no longer available for this Funding Opportunity:

Package No: 1

Assistance Listings:
Competition ID:	FORMS-G
Competition Title:	Use for due dates on or before January 24, 2023
Opportunity Package ID:	PKG00276555
Opening Date:	Sep 28, 2022
Closing Date:	Jan 24, 2023
Agency Contact Information::	eRA Service Desk Monday to Friday 7 am to 8 pm ET http://grants.nih.gov/support/
Who Can Apply::	Organization Applicants
mendatory_forms	SF424 (R & R) [V5.0] PHS 398 Cover Page Supplement [V5.0] Research And Related Other Project Information [V1.4] Project/Performance Site Location(s) [V4.0] Research and Related Senior/Key Person Profile (Expanded) [V4.0] Research & Related Budget [V3.0] PHS 398 Research Plan [V4.0] PHS Human Subjects and Clinical Trials Information [V3.0]
optional_forms	R & R Subaward Budget Attachment(s) Form 5 YR 30 ATT [V3.0] PHS Assignment Request Form [V3.0]

Assistance Listings:
Competition ID:	FORMS-H
Competition Title:	Use for due dates on or after January 25, 2023
Opportunity Package ID:	PKG00278458
Opening Date:	Nov 15, 2022
Closing Date:	Jun 30, 2023
Agency Contact Information::	eRA Service Desk Monday to Friday 7 am to 8 pm ET http://grants.nih.gov/support/
Who Can Apply::	Organization Applicants
mendatory_forms	SF424 (R & R) [V5.0] PHS 398 Cover Page Supplement [V5.0] Research And Related Other Project Information [V1.4] Project/Performance Site Location(s) [V4.0] Research and Related Senior/Key Person Profile (Expanded) [V4.0] Research & Related Budget [V3.0] PHS 398 Research Plan [V5.0] PHS Human Subjects and Clinical Trials Information [V3.0]
optional_forms	R & R Subaward Budget Attachment(s) Form 5 YR 30 ATT [V3.0] PHS Assignment Request Form [V3.0]